Schreiner MediPharm unveils smart Digital Display Label for clinical trial packaging

GERMANY — Schreiner MediPharm has introduced a Digital Display Label designed to digitalize investigational drug packaging in clinical trials, significantly streamlining the relabeling process and improving patient safety.

In clinical trials, regulatory and logistical changes—such as updates to protocol numbers, patient groups, or expiration dates—often require manual relabeling of medical products.

This process is not only time-consuming and costly but can also cause delays. Schreiner MediPharm’s new solution aims to eliminate these inefficiencies by enabling real-time digital updates to label information.

The Digital Display Label is built around a modular, reusable plastic housing that protects sensitive electronic components.

It uses a smart adapter system that allows seamless application to a variety of packaging forms, including transparent containers, with optional light-protection and blinding features integrated.

One of the label’s standout advantages is its ability to update content digitally and instantly, ensuring that clinical staff and patients always have access to the most current drug information—without the need for physical label replacement.

This enhances both efficiency and patient safety while reducing the risk of trial disruptions caused by outdated or incorrect labeling.

In addition to functionality, sustainability is a key feature of the product. The reusable housing and adapter system reduce material waste, while the modular design ensures easy integration with standard pharmaceutical packaging—without the need for structural modifications.

This latest launch follows Schreiner MediPharm’s December 2024 rollout of another major innovation: a cut-through indicator function for closure seals aimed at enhancing pharmaceutical packaging security.

The tamper-evident feature provides a visible, irreversible indication of interference, reinforcing the integrity of the healthcare supply chain.

Unlike traditional multilayer solutions, this single-layer, modular indicator can be customized to suit various seal types and packaging designs.

Additional security enhancements include die-cut contours to expose lateral tampering, raised elements, irregular outer shapes, and guilloche graphic patterns—features that bolster both physical and visual authentication.

The system complies with ISO 21976 and the EU Falsified Medicines Directive (2011/62/EU), offering the highest levels of international security standards.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE